(Reuters) - Pharmaceutical companies spend at least $25 billion
annually in marketing -- much of it to doctors to influence
prescribing habits. At the same time, companies fund the bulk
of the clinical research to expand and approve new treatments,
which advocates said taints patient care.
"I intend to vigorously pursue stronger adherence to these
guidelines, as well as propose a national registry to require
disclosure of payments and gifts," Wisconsin Democratic Sen.
Herb Kohl said at the Washington hearing which was also
broadcast on the Internet.
Read more at Reuters.com Government Filings News
annually in marketing -- much of it to doctors to influence
prescribing habits. At the same time, companies fund the bulk
of the clinical research to expand and approve new treatments,
which advocates said taints patient care.
"I intend to vigorously pursue stronger adherence to these
guidelines, as well as propose a national registry to require
disclosure of payments and gifts," Wisconsin Democratic Sen.
Herb Kohl said at the Washington hearing which was also
broadcast on the Internet.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment